Compare T-Rex 2X Inverse MSTR Daily Target ETF (MSTZ) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
T-Rex 2X Inverse MSTR Daily Target ETF vs Tenet Healthcare Corporation — how do they compare? T-Rex 2X Inverse MSTR Daily Target ETF trades at $2.62 (market cap $94.46M), while Tenet Healthcare Corporation trades at $263.78 (market cap $20.98B). The key difference: Tenet Healthcare Corporation is far larger — about 222.1× T-Rex 2X Inverse MSTR Daily Target ETF's market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, T-Rex 2X Inverse MSTR Daily Target ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold T-Rex 2X Inverse MSTR Daily Target ETF for 8 Days and Tenet Healthcare Corporation for 15 Days on average.
| MSTZ | THC | |
|---|---|---|
Market Cap | $94.46M | $20.98B |
Volume | 104,717,733 | 428,008 |
Sector | Leveraged / Inverse | Health |
52-Week High | $27.92 | $280.77 |
52-Week Low | $2.29 | $161.37 |
Typical Hold Time | 8 Days | 15 Days |
Enterprise Value | — | $32.06B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MSTZ trades at $2.73, up 2.63% today, with a bearish technical signal driven by moving averages. Key financial ratios are unavailable, limiting fundamental clarity. The stock faces resistance at $3, with support near $2. Recent ETF performance news highlights volatility in leveraged funds, but direct company updates are lacking.
Outlook remains uncertain due to missing financial data and bearish technicals. Risks include limited transparency and market volatility. Investment appeal hinges on forthcoming earnings reports and analyst coverage to validate growth prospects and valuation.
Tenet Healthcare (THC) trades at $260.57, up 0.28% with strong technical momentum and bullish moving averages. The stock demonstrates robust fundamentals with consistent earnings beats, a 10.07 P/E ratio, and 53.31% ROE. Recent news highlights strong cash flow supporting capital returns, with Q3 2026 earnings scheduled for October 29. Technical indicators show support at $257 and resistance at $262, with overall bullish sentiment from analysts.
THC presents a compelling investment case with strong profitability metrics and analyst consensus pointing to 8.7% upside to the $283.36 price target. Key risks include declining net cash flow and potential surgical volume pressures. The combination of value pricing, earnings momentum, and institutional support suggests continued upward potential, though investors should monitor cash flow sustainability and Q3 earnings results.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About T-Rex 2X Inverse MSTR Daily Target ETF
MSTZ is a leveraged ETF that seeks daily investment results corresponding to 200% of the inverse (opposite) of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bearish position on MSTR, a company known for its large Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment, as its performance over longer periods may significantly deviate from its stated daily objective.
Read more on MSTZ →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
